Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anna Gorący, Jakub Rosik, Joanna Szostak, Bartosz Szostak, Szymon Retfiński, Filip Machaj & Andrzej Pawlik. (2023) Improving mitochondrial function in preclinical models of heart failure: therapeutic targets for future clinical therapies?. Expert Opinion on Therapeutic Targets 27:7, pages 593-608.
Read now
Read now
Articles from other publishers (25)
James A. Roberts, Richard D. Rainbow & Parveen Sharma. (2023) Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling. International Journal of Molecular Sciences 24:7, pages 6723.
Crossref
Crossref
Marcy Martin, Eric K. N. Gähwiler, Melanie Generali, Simon P. Hoerstrup & Maximilian Y. Emmert. (2023) Advances in 3D Organoid Models for Stem Cell-Based Cardiac Regeneration. International Journal of Molecular Sciences 24:6, pages 5188.
Crossref
Crossref
Rahagir Salekeen, Abu Nasim Haider, Fouzia Akhter, Md Morsaline Billah, Md Emdadul Islam & Kazi Mohammed Didarul Islam. (2022) Lipid oxidation in pathophysiology of atherosclerosis: Current understanding and therapeutic strategies. International Journal of Cardiology Cardiovascular Risk and Prevention 14, pages 200143.
Crossref
Crossref
Jarosław Gorący, Anna Gorący, Aldona Wójcik-Grzeszczuk, Iwona Gorący & Jakub Rosik. (2022) Analysis of Genetic Variants in the Glucocorticoid Receptor Gene NR3C1 and Stenosis of the Carotid Artery in a Polish Population with Coronary Artery Disease. Biomedicines 10:8, pages 1912.
Crossref
Crossref
Ratih Puspita Febrinasari, Stepvia Stepvia & Yusuf Ari Mashuri. (2022) Utilization of Standard Therapy and Adjunctive Isosorbide Dinitrate Pump with Clinical Outcomes in Acute Heart Failure Patients. Open Access Macedonian Journal of Medical Sciences 10:B, pages 909-914.
Crossref
Crossref
Soo Ghee Yeoh, Jia Siang Sum, Jing Yi Lai, W Y Haniff W Isa & Theam Soon Lim. (2021) Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy. Journal of Cardiovascular Translational Research 15:2, pages 360-380.
Crossref
Crossref
Yiming Chen, John Lawrence & Norman Stockbridge. (2021) Days alive out of hospital in heart failure: Insights from the PARADIGM-HF and CHARM trials. American Heart Journal 241, pages 108-119.
Crossref
Crossref
Phiwayinkosi V. Dludla, Tawanda M. Nyambuya, Rabia Johnson, Sonia Silvestri, Patrick Orlando, Sithandiwe E. Mazibuko-Mbeje, Kwazi B. Gabuza, Vuyolwethu Mxinwa, Kabelo Mokgalaboni, Luca Tiano, Christo J. F. Muller, Johan Louw & Bongani B. Nkambule. (2020) Metformin and heart failure–related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials. Heart Failure Reviews 26:6, pages 1437-1445.
Crossref
Crossref
Upendra Kaul, Saumitra Ray, D. Prabhakar, Arun Kochar, Kamal Sharma, Prakash Kumar Hazra, Subhash Chandra, Dharmesh Ramakant Bhai Solanki, Anjan Lal Dutta, Viveka Kumar, M. Srinivas Rao, Abraham Oomman, Sameer Dani, Brian Pinto & T. R. Raghu. (2020) Consensus document: management of heart failure in type 2 diabetes mellitus. Heart Failure Reviews 26:5, pages 1037-1062.
Crossref
Crossref
Corinna N. Lang, Klaus Kaier, Viviane Zotzmann, Peter Stachon, Torben Pottgiesser, Constantin von zur Muehlen, Manfred Zehender, Daniel Duerschmied, Bonaventura Schmid, Christoph Bode, Tobias Wengenmayer & Dawid L. Staudacher. (2020) Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007–2017-insights from a national registry. Clinical Research in Cardiology 110:9, pages 1421-1430.
Crossref
Crossref
Felicia Carotenuto, Vittorio Manzari & Paolo Di Nardo. (2021) Cardiac Regeneration: the Heart of the Issue. Current Transplantation Reports 8:2, pages 67-75.
Crossref
Crossref
Junya Yokoyama, Shigeru Miyagawa, Takami Akagi, Mitsuru Akashi & Yoshiki Sawa. (2021) Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype. PLOS ONE 16:3, pages e0245571.
Crossref
Crossref
Simona Nemska, Max Gassmann, Marie-Louise Bang, Nelly Frossard & Reza Tavakoli. (2021) Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice. Journal of Cardiovascular Pharmacology 78:6, pages 792-801.
Crossref
Crossref
Yana Lerner, Wessal Hanout, Shulamit Fluss Ben-Uliel, Samar Gani, Michal Pellach Leshem & Nir Qvit. (2020) Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases. Current Topics in Medicinal Chemistry 20:32, pages 2904-2921.
Crossref
Crossref
Bach Xuan Tran, Son Nghiem, Clifford Afoakwah, Giang Hai Ha, Linh Phuong Doan, Thao Phuong Nguyen, Tuan Thanh Le, Carl A. Latkin, Cyrus S. H. Ho & Roger C. M. Ho. (2020) Global mapping of interventions to improve the quality of life of patients with cardiovascular diseases during 1990–2018. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Katarzyna Fiedorowicz, Natalia Rozwadowska, Agnieszka Zimna, Agnieszka Malcher, Katarzyna Tutak, Izabela Szczerbal, Karolina Nowicka-Bauer, Magdalena Nowaczyk, Tomasz J. Kolanowski, Wojciech Łabędź, Łukasz Kubaszewski & Maciej Kurpisz. (2020) Tissue-specific promoter-based reporter system for monitoring cell differentiation from iPSCs to cardiomyocytes. Scientific Reports 10:1.
Crossref
Crossref
Tetiana Titko, Lina Perekhoda, Iryna Drapak & Yevgen Tsapko. (2020) Modern trends in diuretics development. European Journal of Medicinal Chemistry 208, pages 112855.
Crossref
Crossref
Toby P. Thomas & Laurel A. Grisanti. (2020) The Dynamic Interplay Between Cardiac Inflammation and Fibrosis. Frontiers in Physiology 11.
Crossref
Crossref
Hai-Jian Sun, Zhi-Yuan Wu, Lei Cao, Meng-Yuan Zhu, Xiao-Wei Nie, De-Jian Huang, Ming-Tai Sun & Jin-Song Bian. (2020) Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology. Pharmacological Research 159, pages 104961.
Crossref
Crossref
Lucy Collins, Pablo Binder, Hongshan Chen & Xin Wang. (2020) Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches. Frontiers in Physiology 11.
Crossref
Crossref
Zh. D. Kobalava, V. V. Medovchshikov & N. B. Yeshniyazov. (2020) Towards quadruple therapy for heart failure with reduced ejection fraction: DAPA-HF secondary analysis data. Russian Journal of Cardiology 25:5, pages 3870.
Crossref
Crossref
Najah Abi-Gerges, Tim Indersmitten, Ky Truong, William Nguyen, Phachareeya Ratchada, Nathalie Nguyen, Guy Page, Paul E. Miller & Andre Ghetti. (2020) Multiparametric Mechanistic Profiling of Inotropic Drugs in Adult Human Primary Cardiomyocytes. Scientific Reports 10:1.
Crossref
Crossref
Hassan N. Althurwi, Maged S. Abdel-Kader, Khalid M. Alharthy, Mohamad Ayman Salkini & Faisal F. Albaqami. (2020) Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis. Molecules 25:8, pages 1786.
Crossref
Crossref
Matthew A. CaporizzoChristina Yingxian ChenKen BediKenneth B. MarguliesBenjamin L. Prosser. (2020) Microtubules Increase Diastolic Stiffness in Failing Human Cardiomyocytes and Myocardium. Circulation 141:11, pages 902-915.
Crossref
Crossref
Piero Pollesello, Tuvia Ben Gal, Dominique Bettex, Vladimir Cerny, Josep Comin-Colet, Alexandr A. Eremenko, Dimitrios Farmakis, Francesco Fedele, Cândida Fonseca, Veli-Pekka Harjola, Antoine Herpain, Matthias Heringlake, Leo Heunks, Trygve Husebye, Visnja Ivancan, Kristian Karason, Sundeep Kaul, Jacek Kubica, Alexandre Mebazaa, Henning Mølgaard, John Parissis, Alexander Parkhomenko, Pentti Põder, Gerhard Pölzl, Bojan Vrtovec, Mehmet B. Yilmaz & Zoltan Papp. (2019) Short-Term Therapies for Treatment of Acute and Advanced Heart Failure—Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?. Journal of Clinical Medicine 8:11, pages 1834.
Crossref
Crossref